The first VanEck ETF Trust - VanEck Pharmaceutical ETF trade was made in Q4 2018.
Since then Jim Simons bought shares six more times and sold shares on eight occasions. The investor completely sold their stake between Q3 2025 and Q1 2026.
Avg closing price
Price range
Sold -9.3k shares
Q1 2026
Avg closing price
$106.85
Price range
$100.73
-
$111.70
Sold 22.5% shares (-2.7k shares)
Q4 2025
Avg closing price
$97.37
Price range
$90.97
-
$104.43
Sold 16.7% shares (-2.4k shares)
Q3 2025
Avg closing price
$87.62
Price range
$82.58
-
$90.36
New holding (+14.4k shares)
Q2 2025
Avg closing price
$86.66
Price range
$80.28
-
$91.78
Sold -19.4k shares
Q4 2024
Avg closing price
$90.33
Price range
$86.03
-
$94.80
Sold 25.1% shares (-6.5k shares)
Q3 2024
Avg closing price
$94.97
Price range
$90.59
-
$99.43
Increased shares by 85.0% (+11.9k shares)
Q2 2024
Avg closing price
$89.27
Price range
$84.87
-
$93.23
Sold 28.6% shares (-5.6k shares)
Q1 2024
Avg closing price
$87.55
Price range
$82.63
-
$90.89
Increased shares by 113.0% (+10.4k shares)
Q4 2023